4-(3-(2,6-difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrazolo[3,4-b]pyridin-5-yl)-N-(2,3-dihydroxypropyl)benzenesulfonamide

ID: ALA4784132

Chembl Id: CHEMBL4784132

PubChem CID: 139369574

Max Phase: Preclinical

Molecular Formula: C25H25F2N5O7S2

Molecular Weight: 609.63

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2n[nH]c3ncc(-c4ccc(S(=O)(=O)NCC(O)CO)cc4)cc23)c1F

Standard InChI:  InChI=1S/C25H25F2N5O7S2/c1-2-9-40(36,37)32-20-8-7-19(26)21(22(20)27)24(35)23-18-10-15(11-28-25(18)31-30-23)14-3-5-17(6-4-14)41(38,39)29-12-16(34)13-33/h3-8,10-11,16,29,32-34H,2,9,12-13H2,1H3,(H,28,30,31)

Standard InChI Key:  WRDPGLXDKNCWGD-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4784132

    ---

Associated Targets(Human)

MAP2K4 Tchem Dual specificity mitogen-activated protein kinase kinase 4 (1051 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRAF Tclin Serine/threonine-protein kinase B-raf (11587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK8 Tchem c-Jun N-terminal kinase 1 (5038 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP2K7 Tchem Dual specificity mitogen-activated protein kinase kinase 7 (1145 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP3K20 Tchem Mixed lineage kinase 7 (1473 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 609.63Molecular Weight (Monoisotopic): 609.1163AlogP: 1.92#Rotatable Bonds: 12
Polar Surface Area: 191.44Molecular Species: NEUTRALHBA: 9HBD: 5
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.76CX Basic pKa: CX LogP: 1.14CX LogD: 1.12
Aromatic Rings: 4Heavy Atoms: 41QED Weighted: 0.15Np Likeness Score: -1.40

References

1.  (2019)  Protein kinase mkk4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death, 
2. Juchum M, Pfaffenrot B, Klövekorn P, Selig R, Albrecht W, Zender L, Laufer SA..  (2022)  Scaffold modified Vemurafenib analogues as highly selective mitogen activated protein kinase kinase 4 (MKK4) inhibitors.,  240  [PMID:35868124] [10.1016/j.ejmech.2022.114584]